Bactest

About:

Bactest offers CYTOMAIA, a microbial contamination testing platform that enables rapid detection.

Top Investors: ACF Investors, Low Carbon Innovation Fund, The FSE Group, Kevin Brown

Description:

Bactest was founded to exploit the clear market potential for a new type of automated instrument which responds to the need for microbial monitoring in a diverse range of locations or applications and which addresses modern safety issues. Existing machines are unable to respond to point of use needs within markets where services are increasingly centralised.

Total Funding Amount:

1.5M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2001-01-01

Contact Email:

p.gaikwad(AT)bactest.com

Founders:

Derek Price

Number of Employees:

1-10

Last Funding Date:

2016-03-31

IPO Status:

Private

Industries: